Anthony Wilson Peck (1933-)
- Date:
- 19 Apr 2001
- Reference:
- WF/M/AV/O/03/04
- Part of:
- Wellcome Foundation Ltd
- Archives and manuscripts
About this work
Description
The folder contains papers, also 2 audio tapes, also photocopy of typed unpublished account of WF's research and development by Miles Weatherall (part), and a CV with a list of his published works.
The interview refers to:
* his education and influence of Cyril Keele, Samson Wright and Franz Hobbiger.
* the company in the early-sixties to 1994 when he retired, early use of personal computers, work with RTP, drug testing.
* drugs - Benzylapiperazine, amphetamines, anti-epilepsy, Prostacyclin, Tracium, Lamotrigine, Wellbutrin, bupropion.
The folders also contain copies of papers by Peck on:
* Lamotrigine
* WF involement in Clinical Trials in Eastern Europe 1980-1990
* Franz Hobbiger Obituary
* Acrivastine (BW825C) a new Antihistamine
* Triprolidine, Clemastine
* Tricyclic Antidepressant Drugs, Bupropion, Nomifensine, Dexamphetamine, Diazepam and 1-Benzylpiperazine.
Publication/Creation
19 Apr 2001
Physical description
5 items
Terms of use
This item is restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2053.
Languages
Where to find it
Location Status Access Closed stores